📰 Ellenk Ritchie News
Ellenk Ritchie News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ellenk Ritchie. Real-time updates on events, politics, business and more.
December 12, 2023
12.12.2023 - Long term follow-up from REVIVE Phase 2 study shows durable hematocrit control, decreased phlebotomy use, long-term tolerability, and no new safety signals in patients with polycythemia veraAnalysis of PACIFIC Phase 2 study shows that rusfertide ... Seite 1
November 2, 2023
Protagonist Reports Third Quarter 2023 Financial Results and Provides ...
November 2, 2023
Protagonist Therapeutics Announces Abstracts Selected for Oral and ...
November 2, 2023
Five rusfertide abstracts accepted for oral and poster presentations at the 65th ASH Annual Meeting and Exposition (ASH2023)Positive topline results from the Phase 2b FRONTIER 1 study of JNJ-2113 (formerly PN-235), the first- and only-in-class oral ...
November 2, 2023
02.11.2023 - Five rusfertide abstracts accepted for oral and poster presentations at the 65th ASH Annual Meeting and Exposition (ASH2023)Positive topline results from the Phase 2b FRONTIER 1 study of JNJ-2113 (formerly PN-235), the first- and only-in-class oral ...